339 related articles for article (PubMed ID: 19076145)
1. Effect of ageing and body mass index on prostate-specific antigen levels among Chinese men in Singapore from a community-based study.
Chia SE; Lau WK; Chin CM; Tan J; Ho SH; Lee J; Cheng C
BJU Int; 2009 Jun; 103(11):1487-91. PubMed ID: 19076145
[TBL] [Abstract][Full Text] [Related]
2. The effect of obesity and lower serum prostate-specific antigen levels on prostate-cancer screening results in American men.
Culp S; Porter M
BJU Int; 2009 Nov; 104(10):1457-61. PubMed ID: 19522868
[TBL] [Abstract][Full Text] [Related]
3. [Relationship between serum prostate-specific antigen levels and body mass index in Beijing men over 50 years of age].
Wang Y; Zhou Z; Tian Y; Shao Q; Chen S; Hong BF; Zhang XH; Ren XH; Sun WX; Wang ZW; Na YQ
Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(24):1681-3. PubMed ID: 19957525
[TBL] [Abstract][Full Text] [Related]
4. Body mass index, prostate-specific antigen, and digital rectal examination findings among participants in a prostate cancer screening clinic.
Price MM; Hamilton RJ; Robertson CN; Butts MC; Freedland SJ
Urology; 2008 May; 71(5):787-91. PubMed ID: 18267334
[TBL] [Abstract][Full Text] [Related]
5. Body mass index influences prostate-specific antigen in men younger than 60 years of age.
Kim YJ; Han BK; Hong SK; Byun SS; Kim WJ; Lee SE
Int J Urol; 2007 Nov; 14(11):1009-12. PubMed ID: 17956528
[TBL] [Abstract][Full Text] [Related]
6. Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening.
Hutterer G; Perrotte P; Gallina A; Walz J; Jeldres C; Traumann M; Suardi N; Saad F; Bénard F; Valiquette L; McCormack M; Graefen M; Montorsi F; Karakiewicz PI
Eur J Cancer; 2007 May; 43(7):1180-7. PubMed ID: 17292604
[TBL] [Abstract][Full Text] [Related]
7. Obesity and screening PSA levels among men undergoing an annual physical exam.
Rundle A; Neugut AI
Prostate; 2008 Mar; 68(4):373-80. PubMed ID: 18189231
[TBL] [Abstract][Full Text] [Related]
8. Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.
Grubb RL; Black A; Izmirlian G; Hickey TP; Pinsky PF; Mabie JE; Riley TL; Ragard LR; Prorok PC; Berg CD; Crawford ED; Church TR; Andriole GL;
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):748-51. PubMed ID: 19258472
[TBL] [Abstract][Full Text] [Related]
9. Obesity, serum prostate specific antigen and prostate size: implications for prostate cancer detection.
Freedland SJ; Platz EA; Presti JC; Aronson WJ; Amling CL; Kane CJ; Terris MK
J Urol; 2006 Feb; 175(2):500-4; discussion 504. PubMed ID: 16406980
[TBL] [Abstract][Full Text] [Related]
10. Associations of demographic and lifestyle characteristics with prostate-specific antigen (PSA) concentration and rate of PSA increase.
Kristal AR; Chi C; Tangen CM; Goodman PJ; Etzioni R; Thompson IM
Cancer; 2006 Jan; 106(2):320-8. PubMed ID: 16342294
[TBL] [Abstract][Full Text] [Related]
11. Body mass index and prostate-specific antigen failure following brachytherapy for localized prostate cancer.
Efstathiou JA; Skowronski RY; Coen JJ; Grocela JA; Hirsch AE; Zietman AL
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1302-8. PubMed ID: 18262732
[TBL] [Abstract][Full Text] [Related]
12. Obesity-PSA relationship: a new formula.
Hekal IA; Ibrahiem EI
Prostate Cancer Prostatic Dis; 2010 Jun; 13(2):186-90. PubMed ID: 20029402
[TBL] [Abstract][Full Text] [Related]
13. Observed effect of age and body mass index on total and complexed PSA: analysis from a national screening program.
Barqawi AB; Golden BK; O'Donnell C; Brawer MK; Crawford ED
Urology; 2005 Apr; 65(4):708-12. PubMed ID: 15833513
[TBL] [Abstract][Full Text] [Related]
14. Obesity and oncological outcome after radical prostatectomy: impact of prostate-specific antigen-based prostate cancer screening: results from the Shared Equal Access Regional Cancer Hospital and Duke Prostate Center databases.
Freedland SJ; Sun L; Kane CJ; Presti JC; Terris MK; Amling CL; Moul JW; Aronson WJ
BJU Int; 2008 Sep; 102(8):969-74. PubMed ID: 18691175
[TBL] [Abstract][Full Text] [Related]
15. Influence of body mass index on prostate-specific antigen failure after androgen suppression and radiation therapy for localized prostate cancer.
Efstathiou JA; Chen MH; Renshaw AA; Loffredo MJ; D'Amico AV
Cancer; 2007 Apr; 109(8):1493-8. PubMed ID: 17340594
[TBL] [Abstract][Full Text] [Related]
16. Influence of anthropometric measurements, age, and prostate volume on prostate-specific antigen levels in men with a low risk of prostate cancer.
Ochiai A; Fritsche HA; Babaian RJ
Urology; 2005 Oct; 66(4):819-23. PubMed ID: 16230145
[TBL] [Abstract][Full Text] [Related]
17. The prevalence of erectile dysfunction among Brazilian men screened for prostate cancer.
Paranhos M; Antunes A; Andrade E; Freire G; Srougi M
BJU Int; 2009 Oct; 104(8):1130-3. PubMed ID: 19426190
[TBL] [Abstract][Full Text] [Related]
18. The association of body mass index and prostate-specific antigen in a population-based study.
Baillargeon J; Pollock BH; Kristal AR; Bradshaw P; Hernandez J; Basler J; Higgins B; Lynch S; Rozanski T; Troyer D; Thompson I
Cancer; 2005 Mar; 103(5):1092-5. PubMed ID: 15668913
[TBL] [Abstract][Full Text] [Related]
19. Comparison of prostate-specific antigen and hormone levels among men in Singapore and the United States.
Cheng I; Yu MC; Koh WP; Pike MC; Kolonel LN; Henderson BE; Stram DO
Cancer Epidemiol Biomarkers Prev; 2005 Jul; 14(7):1692-6. PubMed ID: 16030103
[TBL] [Abstract][Full Text] [Related]
20. Relationship of erythrocyte membrane polyunsaturated fatty acids and prostate-specific antigen levels in Jamaican men.
Ritch CR; Brendler CB; Wan RL; Pickett KE; Sokoloff MH
BJU Int; 2004 Jun; 93(9):1211-5. PubMed ID: 15180607
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
